Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

European AIDS Conference: Studies of atazanavir/ritonavir

Nov. 8, 2007

Analyses highlight efficacy of ambrisentan in pulmonary arterial hypertension

Nov. 8, 2007

MEDI-528 well tolerated to date in phase II asthma trial

Nov. 8, 2007

huC242-DM4: preclinical studies and a phase I trial

Nov. 8, 2007

Phase I trial compares daily, twice daily ARRY-543 in patients with solid tumors

Nov. 8, 2007

Sunitinib safe and active in phase II hepatocellular carcinoma study

Nov. 8, 2007

Preclinical evaluation of Abbott calpain inhibitor points to potential in neurodegenerative disorder

Nov. 7, 2007

Vernalis presents new FAAH inhibitor with in vivo antinociceptive activity at the SfN meeting

Nov. 7, 2007

NS-4591 shows in vivo activity for the treatment of overactive bladder

Nov. 7, 2007

Nicastrin-targeting antibody for cancer and Alzheimer's disease

Nov. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...